245 related articles for article (PubMed ID: 9242187)
1. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.
Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
Circ Res; 1997 Aug; 81(2):258-67. PubMed ID: 9242187
[TBL] [Abstract][Full Text] [Related]
2. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries.
Gauthier KM; Deeter C; Krishna UM; Reddy YK; Bondlela M; Falck JR; Campbell WB
Circ Res; 2002 May; 90(9):1028-36. PubMed ID: 12016270
[TBL] [Abstract][Full Text] [Related]
3. Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.
Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
Am J Physiol; 1999 Nov; 277(5):H2098-108. PubMed ID: 10564166
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs.
Pratt PF; Li P; Hillard CJ; Kurian J; Campbell WB
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1113-21. PubMed ID: 11179054
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
6. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery.
Kühberger E; Groschner K; Kukovetz WR; Brunner F
Br J Pharmacol; 1994 Dec; 113(4):1289-94. PubMed ID: 7889285
[TBL] [Abstract][Full Text] [Related]
7. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
Campbell WB; Deeter C; Gauthier KM; Ingraham RH; Falck JR; Li PL
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1656-64. PubMed ID: 11959628
[TBL] [Abstract][Full Text] [Related]
8. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.
Hecker M; Bara AT; Bauersachs J; Busse R
J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):407-14. PubMed ID: 7738833
[TBL] [Abstract][Full Text] [Related]
9. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle.
Fang X; Kaduce TL; Weintraub NL; VanRollins M; Spector AA
Circ Res; 1996 Oct; 79(4):784-93. PubMed ID: 8831502
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-dependent relaxation to arachidonic acid in porcine coronary artery: is there a fourth pathway?
Lonigro AJ; Weintraub NL; Branch CA; Stephenson AH; McMurdo L; Sprague RS
Pol J Pharmacol; 1994; 46(6):567-77. PubMed ID: 7620517
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
Stork AP; Cocks TM
Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
[TBL] [Abstract][Full Text] [Related]
13. Different involvement of nitric oxide in endothelium-dependent relaxation of porcine pulmonary artery and vein: influence of hypoxia.
Félétou M; Girard V; Canet E
J Cardiovasc Pharmacol; 1995 Apr; 25(4):665-73. PubMed ID: 7596137
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid.
Eckman DM; Hopkins N; McBride C; Keef KD
Br J Pharmacol; 1998 May; 124(1):181-9. PubMed ID: 9630358
[TBL] [Abstract][Full Text] [Related]
15. 14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries.
Gauthier KM; Edwards EM; Falck JR; Reddy DS; Campbell WB
Hypertension; 2005 Apr; 45(4):666-71. PubMed ID: 15699460
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells.
Fang X; Kaduce TL; Weintraub NL; Spector AA
Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):367-71. PubMed ID: 9430380
[TBL] [Abstract][Full Text] [Related]
17. Coronary microvascular responses after exposure to iodinated contrast media.
Piana RN; Banitt PF; Nunez BN; Dai HB; Sellke FW
Invest Radiol; 1994 Oct; 29(10):877-81. PubMed ID: 7852038
[TBL] [Abstract][Full Text] [Related]
18. 14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.
Bukhari IA; Gauthier KM; Jagadeesh SG; Sangras B; Falck JR; Campbell WB
J Pharmacol Exp Ther; 2011 Jan; 336(1):47-55. PubMed ID: 20881018
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin-induced, N omega-nitro-L-arginine-insensitive endothelium-dependent relaxation of porcine coronary arteries is not mediated by bioassayable relaxing substances.
Kauser K; Rubanyi GM
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S101-4. PubMed ID: 1282939
[TBL] [Abstract][Full Text] [Related]
20. 14,15-epoxyeicosa-5(Z)-enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries.
Gauthier KM; Jagadeesh SG; Falck JR; Campbell WB
Hypertension; 2003 Oct; 42(4):555-61. PubMed ID: 12953017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
